Menu Search
Equities

abrdn Healthcare Investors

HQH:NYQ

abrdn Healthcare Investors

Actions
FinancialsClosed End Investments
  • Price (USD)18.48
  • Today's Change-0.25 / -1.33%
  • Shares traded154.50k
  • 1 Year change+24.03%
  • Beta0.7325
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year abrdn Healthcare Investors grew revenues 24.44% from 8.27m to 10.29m while net income improved from a loss of 194.23m to a gain of 56.33m.
Gross margin-4.00%
Net profit margin730.94%
Operating margin-11.11%
Return on assets7.29%
Return on equity7.34%
Return on investment7.34%
More ▼

Cash flow in USDView more

SmartText is unavailable
Cash flow per share--
Price/Cash flow per share--
Book value per share19.90
Tangible book value per share19.90
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 127.77%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)112.07%
EPS growth(5 years)-7.02
EPS (TTM) vs
TTM 1 year ago		1,652.05
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.